Seigne J - Search Results

1

Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Mora LB, et al. Among authors: seigne j. Cancer Res. 2002 Nov 15;62(22):6659-66. Cancer Res. 2002. PMID: 12438264

2

Prostate adenocarcinoma: cellular and molecular abnormalities.

Mora LB, Buettner R, Ahmad N, Bassel Y, Jove R, Seigne JD. Mora LB, et al. Among authors: seigne jd. Cancer Control. 2001 Nov-Dec;8(6):551-61. doi: 10.1177/107327480100800612. Cancer Control. 2001. PMID: 11807425 Free article. Review. No abstract available.

3

Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma.

Antonia SJ, Seigne J, Diaz J, Muro-Cacho C, Extermann M, Farmelo MJ, Friberg M, Alsarraj M, Mahany JJ, Pow-Sang J, Cantor A, Janssen W. Antonia SJ, et al. Among authors: seigne j. J Urol. 2002 May;167(5):1995-2000. J Urol. 2002. PMID: 11956426 Clinical Trial.

4

Treatment decision-making strategies and influences in patients with localized prostate carcinoma.

Gwede CK, Pow-Sang J, Seigne J, Heysek R, Helal M, Shade K, Cantor A, Jacobsen PB. Gwede CK, et al. Among authors: seigne j. Cancer. 2005 Oct 1;104(7):1381-90. doi: 10.1002/cncr.21330. Cancer. 2005. PMID: 16080181 Free article.

5

Contemporary management of superficial bladder cancer.

Pow-Sang JM, Seigne JD. Pow-Sang JM, et al. Among authors: seigne jd. Cancer Control. 2000 Jul-Aug;7(4):335-9. doi: 10.1177/107327480000700402. Cancer Control. 2000. PMID: 10895127 Free article. Review.

6

Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: a review of the H. Lee Moffitt Cancer Center experience.

Torres-Roca JF, Cantor AB, Shukla S, Montejo ME, Friedland J, Seigne JD, Heysek R, Pow-Sang J. Torres-Roca JF, et al. Among authors: seigne jd. Urol Oncol. 2006 Sep-Oct;24(5):384-90. doi: 10.1016/j.urolonc.2005.12.003. Urol Oncol. 2006. PMID: 16962486

7

Investigation of the safety and accuracy of intraoperative gamma probe directed biopsy of bone scan detected rib abnormalities in prostatic adenocarcinoma.

Thurman SA, Robinson LA, Ahmad N, Pow-Sang JM, Lockhart JL, Seigne J. Thurman SA, et al. Among authors: seigne j. J Urol. 2003 Apr;169(4):1341-4. doi: 10.1097/01.ju.0000053244.56520.4b. J Urol. 2003. PMID: 12629356

8

The specific role of isoflavones in reducing prostate cancer risk.

Kumar NB, Cantor A, Allen K, Riccardi D, Besterman-Dahan K, Seigne J, Helal M, Salup R, Pow-Sang J. Kumar NB, et al. Among authors: seigne j. Prostate. 2004 May 1;59(2):141-7. doi: 10.1002/pros.10362. Prostate. 2004. PMID: 15042614 Clinical Trial.

9

Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer.

Park J, Chen L, Shade K, Lazarus P, Seigne J, Patterson S, Helal M, Pow-Sang J. Park J, et al. Among authors: seigne j. J Urol. 2004 Jun;171(6 Pt 1):2484-8. doi: 10.1097/01.ju.0000117748.44313.43. J Urol. 2004. PMID: 15126881

10

A feasibility study of gene gun mediated immunotherapy for renal cell carcinoma.

Seigne J, Turner J, Diaz J, Hackney J, Pow-Sang J, Helal M, Lockhart J, Yu H. Seigne J, et al. J Urol. 1999 Oct;162(4):1259-63. J Urol. 1999. PMID: 10492175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters